Summer Sale
50% off Premium Yearly
Electa AB (EKTAB-SS)
Financials 
Technical Analysis (He recommends you take a half position only because these Top Picks are trading at multiples that are higher than average, but are still attractive as long-term investments.) Radiation therapy for brain cancer. A Swedish firm where the suffering is on the hardware side, but they also supply all the software that goes with it. Trading at a PEG ratio of about 1. They are #1 in their industry in that category. Do a lot of business in the Middle East and Asia and demand there is picking up as middle incomes begin to grow.
David Driscoll- «
- ‹
- 1
- ›
- »
Electa AB (EKTAB-SS) Frequently Asked Questions
What is Electa AB stock symbol?
Electa AB is a OTC stock, trading under the symbol EKTAB-SS on the undefined (undefined). It is usually referred to as or EKTAB-SS
Is Electa AB a buy or a sell?
In the last year, no analyst issued a Buy, Sell, or Hold rating on EKTAB-SS on Stockchase. Read the latest expert commentary for Electa AB.
Is Electa AB a good investment or a top pick?
Electa AB was recommended as a Top Pick by David Driscoll on 2013-11-08. Read the latest stock experts ratings for Electa AB.
Why is Electa AB stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Electa AB.
Is Electa AB worth watching?
Electa AB is covered by Stockchase experts and is worth watching.
(BNN had the date as Nov 28/13, but I show Nov 8/13.) (A Top Pick Nov 8/13. Down 3.75%.) Healthcare. The Swedish krona has done well so there is some currency growth. This is another situation where at the back end of the year, if their earnings come back up, they have the ability to see their earnings pop. Dividend is growing at roughly 20%-25% a year. Still thinks they have some terrific growth to come.